Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Welcome, everyone. My name is Jess Fye, biotech analyst at JPMorgan, and we're delighted to be continuing the 44th Annual JPMorgan Healthcare Conference today with Vertex.
You're going to hear a presentation from the management team and then we're going to go into some Q&A. So if you're in the room here, just raise your hands, someone will bring you a microphone or if you're listening at home, you can submit a question for the portal, and I can read it up here on stage.
So with that, let me pass it over to Vertex' CEO, Reshma Kewalramani.
Thanks, Jess, and thank you to JPMorgan for hosting us. We're at a slightly different time and a slightly different venue for those of you who come every year and it's very good to see you all. In the event, I'm not the first to wish you a happy New Year. Let me be amongst the first on behalf of the entire Vertex team, we're really happy to be here, and we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
